Robert G. Finizio

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Boca Raton, FL
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Stephen C. Glover as Attorney-in-Fact for Robert G. Finizio pursuant to Power of Attorney
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Robert G. Finizio

Form 4 holding CEO, Director

TherapeuticsMD, Inc.

Security class
Restricted Stock Units
Shares / value
746,667
Estimated value
$2,716,449
Report date
01 Jul 2021
Price
$3.64
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding CEO, Director

TherapeuticsMD, Inc.

Security class
Performance Stock Units
Shares / value
1,493,333
Estimated value
$2,589,439
Report date
01 Jul 2021
Price
$1.73
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

ZyVersa Therapeutics, Inc.

Security class
Stock Options
Shares / value
132
Estimated value
Report date
24 May 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Robert G. Finizio

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .